Purpose Frailty in older adult cancer survivors after cancer treatments is associated with
various health outcomes. However, there is less agreement on how frailty affects symptoms …

Most patients with metastatic prostate cancer (mPCa) are older. In addition, current geriatric
oncology guidelines suggest that all cancer patients aged over 70 years should undergo a …

Background With population aging, the number of frail patients with pancreatic cancer has
increased. The Clinical Frailty Scale (CFS) is a simple and validated tool to assess frailty …

Introduction As treatment options for metastatic castration-resistant prostate cancer
(mCRPC) expand and its patient population ages, consideration of frailty is increasingly …

Background There is limited information about the population characteristics and adverse
health outcomes of older cancer patients in China. This study aimed to describe the …

Background: Androgen deprivation therapy (ADT) is a mainstay of prostate cancer in both
adjuvant and palliative settings. Since androgens are crucial for functional status and …

BACKGROUND: Frailty has been linked to an increased risk of adverse outcomes among
older men with prostate cancer (PCa), which in turn impacts survival. We evaluated the …

Background The Clinical Frailty Scale (CFS) is a well-established tool that has been widely
employed to assess patients' frailty status and to predict clinical outcomes in the acute phase …

In urologic oncology, which often involves older patients, it is important to consider how to
manage their care appropriately. Geriatric assessment (GA) is a method that can address …

Background: Following a prostate cancer (PC) diagnosis, treatment-related symptoms may
result in diminished quality of life (QoL). Improved diet and increased exercise may improve …